Company / Operating Income per Share
ImmunityBio, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.30
FY2025
5-year range
-$0.88 / -$0.30
FY2021-FY2025
Trend
+41.5%
vs FY2024
Sector context
#67 of 201
Health Care
What the data says
At $-0.30, ImmunityBio, Inc.'s operating income per share ranks #67 of 201 in the Health Care sector. Operating Income per Share has increased for 3 consecutive years, from $-0.88 in FY2022 to $-0.30 in FY2025.
Based on SEC 10-K filings.
-0.30 in FY2025.
Improved from $-0.86 to $-0.30 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#67 of 201 in Health CareTop 33% of 201This company -$0.30 Sector average -$3.23
▼
+90.7% above sector average
Key checks
Key Insights
- ImmunityBio, Inc.'s operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 41.5% year-over-year.
- Ranks #67 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -7.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.30 | +41.5% |
| FY2024 | -$0.51 | +40.3% |
| FY2023 | -$0.86 | +2.7% |
| FY2022 | -$0.88 | -116.0% |
| FY2021 | -$0.41 | +81.8% |
| FY2020 | -$2.24 | -13.5% |
| FY2019 | -$1.98 | -25.4% |
| FY2018 | -$1.58 | +45.9% |
| FY2017 | -$2.91 | -4149.6% |
| FY2016 | -$0.07 | +100.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026